Stoke Therapeutics Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases. | Eureka Therapeutics Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.
| AOBiome AOBiome is a pioneer in bacterial therapy.
We represent a new approach to skin health that focuses on the restoring good bacteria to your biome | Vyome Therapeutics Vyome Therapeutics is a biopharmaceutical company engaged in the development of novel drugs for antibiotic-resistant acne and other opportunist pathogens. | Escalier Biosciences Escalier Biosciences is a biopharmaceutical company developing small molecule therapeutics RORγt for psoriasis and other autoimmune disorders treatment. | |
Founding Date | Founding Date 2014 | Founding Date 2006 | Founding Date 2013 | Founding Date 2010 | Founding Date N/A |
Type | Type Public | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Bedford, US HQ Cambridge, US | Locations Emeryville, US HQ | Locations Cambridge, US HQ | Locations Princeton, US HQ Delhi, IN Vadodara, IN | Locations Nijmegen, NL HQ Encinitas, US |
Employees | Employees 1106% decrease | Employees 442% decrease | Employees 16 | Employees 19 | Employees N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 45m (almost 5 years ago) | Latest funding round $ 30m (about 8 years ago) | Latest funding round $ 21.9m (almost 6 years ago) | Latest funding round $ 19m (almost 7 years ago) |
Total funding raised | Total funding raised $ 130m | Total funding raised $ 130.4m | Total funding raised $ 38.7m | Total funding raised $ 48.2m | Total funding raised $ 19m |